"We don't just want to give kids with rare diseases hope, we want to give them a better life and better treatments."
Keith Foster is the Chief Scientific Officer of Sutura Therapeutics, a company he founded to develop precision gene therapies for rare diseases, starting with Duchenne's Muscular Dystrophy.
Sutura is a genuinely patient-focused company, and if you've ever wondered what patient-centricity truly is, Keith's interview is a must-listen.
Enjoy!
Create your
podcast in
minutes
It is Free